Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
Authors
Keywords
-
Journal
MOLECULES
Volume 20, Issue 11, Pages 20551-20568
Publisher
MDPI AG
Online
2015-11-24
DOI
10.3390/molecules201119717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Lactate-Induced Response to Hypoxia
- (2015) Dong Chul Lee et al. CELL
- Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation
- (2014) Yong Rae Hong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility
- (2014) Weibo Luo et al. MOLECULAR BIOLOGY OF THE CELL
- Regulation of Wound Healing and Fibrosis by Hypoxia and Hypoxia-Inducible Factor-1
- (2014) Robin J Ruthenborg et al. MOLECULES AND CELLS
- Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
- (2014) Holger K. Eltzschig et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of Proline Analogues on Activity of Human Prolyl Hydroxylase and the Regulation of HIF Signal Transduction Pathway
- (2014) Xiaoyan Ma et al. PLoS One
- PHD3 regulates EGFR internalization and signalling in tumours
- (2014) Boyan K. Garvalov et al. Nature Communications
- Prolyl 4-hydroxylases, master regulators of the hypoxia response
- (2013) J. Myllyharju Acta Physiologica
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses
- (2013) Michael H. Rabinowitz JOURNAL OF MEDICINAL CHEMISTRY
- Loss of Epithelial Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Accelerates Skin Wound Healing in Mice
- (2013) Joanna Kalucka et al. MOLECULAR AND CELLULAR BIOLOGY
- A Novel Prolyl Hydroxylase Inhibitor Protects Against Cell Death After Hypoxia
- (2013) Satoru Kontani et al. NEUROCHEMICAL RESEARCH
- Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
- (2013) Xiongliang Zhang et al. PLoS One
- Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
- (2013) Z. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of IL-1 -induced NF- B by hydroxylases links key hypoxic and inflammatory signaling pathways
- (2013) C. C. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia and inflammation are two sides of the same coin
- (2013) K. Bartels et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF1A Reduces Acute Lung Injury by Optimizing Carbohydrate Metabolism in the Alveolar Epithelium
- (2013) Tobias Eckle et al. PLOS BIOLOGY
- Dynamic Combinatorial Chemistry Employing Boronic Acids/Boronate Esters Leads to Potent Oxygenase Inhibitors
- (2012) Marina Demetriades et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition: Robust New Target or Another Big Bust for Stroke Therapeutics?
- (2012) Saravanan S Karuppagounder et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response
- (2012) Liang Xie et al. JOURNAL OF CLINICAL INVESTIGATION
- Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)
- (2012) Shannon C. Flagg et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- 1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia
- (2012) Petr Vachal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reporter Ligand NMR Screening Method for 2-Oxoglutarate Oxygenase Inhibitors
- (2012) Ivanhoe K. H. Leung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia
- (2012) Tobias Eckle et al. NATURE MEDICINE
- Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides
- (2011) Hyuk Sung Kwon et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of a new molecular probe ML228: An activator of the hypoxia inducible factor (HIF) pathway
- (2011) Jimmy R. Theriault et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
- (2011) Weibo Luo et al. CELL
- HIF-1α dysfunction in diabetes
- (2011) Hariharan Thangarajah et al. CELL CYCLE
- HIF prolyl hydroxylase inhibitors for anemia
- (2011) Eugene Muchnik et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
- (2011) T. D. Barrett et al. MOLECULAR PHARMACOLOGY
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors
- (2011) Kenneth Thirstrup et al. PHARMACOLOGICAL RESEARCH
- von Hippel–Lindau β-domain–luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay
- (2010) Sungchae Hong et al. ANALYTICAL BIOCHEMISTRY
- Utilization of an In Vivo Reporter for High Throughput Identification of Branched Small Molecule Regulators of Hypoxic Adaptation
- (2010) Natalya A. Smirnova et al. CHEMISTRY & BIOLOGY
- Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia
- (2010) Lin Yan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Prolyl Hydroxylase Domain (PHD) 2 Affects Cell Migration and F-actin Formation via RhoA/Rho-associated Kinase-dependent Cofilin Phosphorylation
- (2010) Sabine Vogel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotection by Dimethyloxalylglycine following Permanent and Transient Focal Cerebral Ischemia in Rats
- (2010) Simon Nagel et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss
- (2010) Y. A. Minamishima et al. SCIENCE
- HIF pathway mutations and erythrocytosis
- (2010) Mary Frances McMullin Expert Review of Hematology
- Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues
- (2010) Mark D. Rosen et al. ACS Medicinal Chemistry Letters
- Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-α Expression
- (2009) Kotaro Takeda et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HIF-1α peptide derivatives with modifications at the hydroxyproline residue as activators of HIF-1α
- (2009) Dae-Ro Ahn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
- (2009) Qing Zhang et al. CANCER CELL
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Application of a Proteolysis/Mass Spectrometry Method for Investigating the Effects of Inhibitors on Hydroxylase Structure
- (2009) Christopher J. Stubbs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
- (2009) Peter Fraisl et al. NATURE REVIEWS DRUG DISCOVERY
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells
- (2009) Shi-Hua Liao et al. PROTEOMICS
- Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases
- (2009) Rasheduzzaman Chowdhury et al. STRUCTURE
- Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases
- (2009) Kathryn M Oliver et al. ARTHRITIS RESEARCH & THERAPY
- In vivofunctions of the prolyl-4-hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues
- (2008) D. M. Katschinski Acta Physiologica
- Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology
- (2008) Jennifer H. Dao et al. ANALYTICAL BIOCHEMISTRY
- Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors
- (2008) Mike Frohn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hypoxia-Inducible Factor-1 Is Central to Cardioprotection
- (2008) Tobias Eckle et al. CIRCULATION
- Baicalein Induces Functional Hypoxia-Inducible Factor-1 and Angiogenesis
- (2008) H. Cho et al. MOLECULAR PHARMACOLOGY
- Stabilization of HIF-1 is critical to improve wound healing in diabetic mice
- (2008) I. R. Botusan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis
- (2007) Eoin P. Cummins et al. GASTROENTEROLOGY
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
- (2007) Andreas Robinson et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started